| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.28▼ | 1.29▼ | 1.30▼ | 1.21▼ | 1.37▼ |
| MA10 | 1.29▼ | 1.27▲ | 1.24▲ | 1.19▼ | 1.29▼ |
| MA20 | 1.30▼ | 1.21▲ | 1.23▲ | 1.33▼ | 1.13▲ |
| MA50 | 1.25▲ | 1.32▼ | 1.37▼ | 1.23▼ | 1.36▼ |
| MA100 | 1.31▼ | 1.34▼ | 1.26▲ | 1.09▲ | 1.96▼ |
| MA200 | 1.32▼ | 1.16▲ | 1.13▲ | 1.28▼ | 2.87▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.007▼ | 0.019▲ | 0.020▲ | -0.029▼ | 0.047▲ |
| RSI | 48.922▼ | 52.309▲ | 50.199▲ | 41.643▼ | 47.061▼ |
| STOCH | 58.547 | 68.598 | 77.754 | 39.685 | 76.599 |
| WILL %R | -44.793 | -37.209 | -32.653 | -66.006 | -45.122 |
| CCI | -60.666 | 56.342 | 78.517 | -51.421 | 19.405 |
|
Friday, June 13, 2025 02:29 PM
TherapeuticsMD Inc. closed 52.05% short of its 52-week high of $2.44, which the company achieved on January 3rd.
|
|
Friday, June 06, 2025 04:20 PM
BOCA RATON, Fla., May 13, 2025--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results ...
|
|
Friday, June 06, 2025 04:20 PM
BOCA RATON, Fla., May 13, 2025--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/06/25 | 1.21 | 1.21 | 1.1653 | 1.17 | 13,971 |
| 12/06/25 | 1.20 | 1.2299 | 1.1714 | 1.20 | 10,565 |
| 11/06/25 | 1.19 | 1.26 | 1.17 | 1.20 | 14,031 |
| 09/06/25 | 1.21 | 1.33 | 1.1707 | 1.25 | 56,113 |
| 06/06/25 | 1.13 | 1.36 | 1.13 | 1.25 | 151,418 |
| 05/06/25 | 1.14 | 1.1752 | 1.1001 | 1.11 | 41,291 |
| 04/06/25 | 1.06 | 1.15 | 1.06 | 1.13 | 78,684 |
| 03/06/25 | 1.14 | 1.1813 | 1.0001 | 1.08 | 264,208 |
| 02/06/25 | 1.44 | 1.4707 | 1.06 | 1.10 | 335,510 |
| 30/05/25 | 1.49 | 1.4998 | 1.45 | 1.46 | 30,557 |
|
|
||||
|
|
||||
|
|